Steris PLC (BSP:S1TE34)
R$ 60 6.95 (13.1%) Market Cap: 118.58 Bil Enterprise Value: 133.52 Bil PE Ratio: 61.78 PB Ratio: 3.69 GF Score: 33/100

STERIS plc at Raymond James Institutional Investors Conference Transcript

Mar 04, 2019 / 01:40PM GMT
Lawrence Soren Keusch;Michael J. Tokich
Raymond James & Associates, Inc., Research Division - MD;STERIS plc - Senior

Okay. Good morning, everyone. Welcome to Day 1 of the Raymond James Institutional Investors Conference here in Orlando. Hope everybody's enjoying the nice weather. I came down from Boston last night, so I am not upset about missing the 8 inches of snow that we're getting today, although my kids are excited because they missed school.

With us today is STERIS. STERIS has been a long-time participant in this conference. They've grown significantly over the past several years and really are a leader in infection control and prevention across a variety of care settings. With us today is Mike Tokich. Mike is Senior Vice President, Treasurer and Chief Financial Officer. And also with us is Julie Winter, who is Director of Investor Relations.

I'll pass it over to Mike for about 15 minutes of prepared remarks and then we'll open it up and have about 10 minutes of Q&A before the breakout session.

So with that, Mike, it's all yours.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot